Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 1:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2641–2664 of 4,346 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Time Management Clear all

Conditions: Hypercholesterolaemia
Interventions: Alirocumab SAR236553, Current auto-injector device (AI), New auto-injector device (SYDNEY), Atorvastatin, Rosuvastatin; Drug · Device
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 13
States / cities: Los Angeles, California • Jacksonville, Florida • Ponte Vedra, Florida + 8 more

Conditions: POTS - Postural Orthostatic Tachycardia Syndrome
Interventions: Questionnaires to be competed, Provide list of medication and lifetime events, Use phone App to record new life events, Will wear an activity monitor, Periodic 24-hour urine sodium check, A fMRI scan, A bedside tilt test will be performed, IV placed to collect blood samples, Stool Sample; Behavioral · Device · Other + 1 more
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 12 Years to 21 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Pemphigus Vulgaris
Interventions: intravenous immunoglobulin, cyclophosphamide; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Atrial Fibrillation
Interventions: AFib detection with wearable smart watch; Other
Lead sponsor: Kansas City Heart Rhythm Research Foundation; Other
Eligibility: 18 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Healthy Subject
Interventions: Informational Intervention, Media Intervention, Survey Administration; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years to 25 Years
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Trauma
Interventions: Neurofeedback Intervention, standard of care; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 6 Years to 12 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Mental Impairment
Interventions: Full Service, Basic Service; Behavioral
Lead sponsor: Westat; Other
Eligibility: 18 Years to 49 Years
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 52
States / cities: Lancaster, California • Denver, Colorado • St. Petersburg, Florida + 43 more

Conditions: Anemia, Sickle Cell
Interventions: Mindfulness-based Stress Reduction; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Migraine Disorders
Interventions: Serotona Plus and dietary behavior management; Behavioral
Lead sponsor: Dynamic Health Resources; Industry
Eligibility: 18 Years to 72 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Chesapeake, Virginia

Conditions: Trachoma
Interventions: Surveillance and treatment with azithromycin of newcomer and traveler families, Usual care; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: Not listed
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Suicide, Suicide Attempt, Adolescent Suicidality, Suicide Ideation
Interventions: Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide.; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Infant, Premature, Diseases
Interventions: Multisensory early oral administration of human milk; Other
Lead sponsor: Loyola University; Other
Eligibility: 23 Weeks to 32 Weeks
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 2
States / cities: Maywood, Illinois

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Levosimendan, Placebo for levosimendan; Drug
Lead sponsor: Orion Corporation, Orion Pharma; Industry
Eligibility: 18 Years to 120 Years
Enrollment: 496 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 48
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 35 more

Conditions: Multiple Myeloma
Interventions: ARM A EARLY INTERVENTION GROUP, ARM B DELAYED INTERVENTION GROUP; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Hypertensive Renal Disease
Interventions: USUAL - take your BP Meds as you usually do, HS DOSING, ADD On Dosing; Behavioral · Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 16
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 12 more

Conditions: Cigarette Smoking, Hypertension
Interventions: Varenicline, behavioral therapy; Drug · Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Cystic Fibrosis
Interventions: Open-platform patient support system (PSS) app; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 15 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Atherosclerotic Cardiovascular Disease, Metabolic Syndrome
Interventions: Health Education, Transcendental Meditation; Behavioral
Lead sponsor: Robert Schneider, MD; Other
Eligibility: 55 Years and older · Female only
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Atlanta, Georgia

Conditions: Alcoholism, Alcohol Use Disorder (AUD)
Interventions: Topiramate, Medical Management, Inactive Placebo; Drug · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 70 Years
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Educational Activities
Interventions: PEDSS - symptom management, PEDSS - support for the caregiver; Other
Lead sponsor: Duke University; Other
Eligibility: 3 Years to 17 Years
Enrollment: 289 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 15
States / cities: Miami, Florida • Chicago, Illinois • Winfield, Illinois + 12 more

Conditions: Pediatric Obesity
Interventions: LAUNCH, Pediatrician Counseling; Behavioral · Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 2 Years to 5 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Early Stage Estrogen Receptor (ER) Positive Breast Cancer
Interventions: Active Surveillance; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 70 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Multiple Myeloma
Interventions: TAA-specific CTLs, TAA-specific CTLs- fixed dose; Biological
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 3
States / cities: Houston, Texas

Conditions: Bipolar Disorder Family Members
Interventions: Psychoeducation, Psychoeducation - Delayed; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx With Its Numerous Co-morbidities?

Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus

Accuracy of Rhythm Detection by a Wearable Smart Watch for Cardiac Arrhythmias (The WATCH-RHYTHM Study)

mHealth Intervention in Increasing HPV Vaccinations in College Students

A Trial of Neurofeedback as an Adjunctive Treatment for Youth in Outpatient Mental Health Settings

Supported Employment Demonstration

MBSR for Pain Catastrophizing in SCD

American Migraine Prevention Study

A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial

Lock and Protect: Reducing Adolescent Access to Lethal Means of Suicide

Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma

African American Study of Kidney Disease and Hypertension ABPM Pilot Study

Smoking Study With Behavioral Therapy for Hypertensive Patients

Technology-enabled Patient Support System for Self-management of CF

Multicenter Trial of Meditation and Health Education for Cardiometabolic Disease in Black Women

A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers

Parent Educational Discharge Support Strategies

Behavioral Rx & Nutrition in Pediatric Chronic Disease

Active Surveillance in Older Women With ER+ Breast Cancer

Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

A Psychoeducation Intervention for Caregivers of Patients With Bipolar Disorder